Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Federal Trade Commission
Novartis
Teva
Chinese Patent Office
Covington
Farmers Insurance
McKinsey
Deloitte
Dow

Generated: August 17, 2017

DrugPatentWatch Database Preview

Zydus Pharms Usa Company Profile

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA, and what generic and branded alternatives to ZYDUS PHARMS USA drugs are available?

ZYDUS PHARMS USA has one hundred and twelve approved drugs.

There are nine tentative approvals on ZYDUS PHARMS USA drugs.

Summary for Applicant: Zydus Pharms Usa

Patents:0
Tradenames:98
Ingredients:98
NDAs:112
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
ACYCLOVIR
acyclovir
CAPSULE;ORAL204313-001Mar 25, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
LEVOFLOXACIN
levofloxacin
TABLET;ORAL077652-001Sep 7, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
DIPYRIDAMOLE
dipyridamole
TABLET;ORAL040874-002Jan 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
MIRTAZAPINE
mirtazapine
TABLET, ORALLY DISINTEGRATING;ORAL205798-003Jun 1, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
FLUCONAZOLE
fluconazole
TABLET;ORAL208963-003Feb 16, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ZYDUS PHARMS USA drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Teva
Accenture
Novartis
Julphar
Mallinckrodt
Cerilliant
US Department of Justice
UBS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot